PharmiNews

The Directory of Pharma Companies and News

Sun Pharma

Category:
Category:

Sun Pharma News

DateNews
2017-01-04Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera™ for Treatment of Dry E... (PDF)
2016-12-22Sun Pharma to acquire branded oncology product Odomzo® for global markets (PDF)
2016-12-12Sun Pharma & Moebius Medical sign deal to develop novel liposomal non-opiod pain product for osteoarthritis (PDF)
2016-11-30FY17 Q2 Financial Result - Transcript (PDF)
2016-11-28Sun Pharma launches first branded ophthalmic product, BromSite in USA (PDF)
2016-11-23Sun Pharma to acquire Biosintez in Russia (PDF)
2016-11-10FY17 Q2 Financial Press Release
2016-10-27Sun Pharma Announces US Launch of Authorized Generics for Olmesartan (PDF)
2016-10-26Sun Pharma to Acquire Ocular Technologies (PDF)
2016-10-26Sun Pharma Q2 FY17 financial result on November 10, 2016 (PDF)
2016-10-19Sun Pharma & ICGEB announce new exclusive collaboration to develop novel dengue vaccine for India & Global markets (PDF)
2016-10-17Media Invitation For October 19 Announcement (PDF)
2016-10-03Revital H Woman launches ‘Healthy Conversations’ initiative (PDF)
2016-10-01Sun Pharma to Announce Late-Breaking Results for Tildrakizumab (PDF)
2016-09-06Sun Pharma announces distribution alliance with Mitsubishi Tanabe Pharma Corporation in Japan (PDF)
2016-08-29FY17 Q1 Financial Result - Transcript (PDF)
2016-08-12FY17 Q1 Financial Press Release (PDF)
2016-08-08Sun Pharma extends Imatinib Mesylate Savings Card program benefits for patients in USA (PDF)
2016-08-02Sun Pharma announces US FDA approval for generic Glumetza® (PDF)
2016-08-01Sun Pharma to announce first quarter results on August 12, 2016 (PDF)
2016-07-27Sun Pharma and Almirall enter into a License Agreement for Tildrakizumab in Europe for Psoriasis (PDF)
2016-07-20Sun Pharma announces US FDA approval for generic Crestor® (PDF)
2016-07-18Press Release SPARC licenses Elepsia XR to Sun Pharma (PDF)
2016-07-11Press Release Sun Pharma launches Gemcitabine InfuSMART (PDF)
2016-06-23Sun Pharma Announces Buyback of Equity Shares (PDF)
2016-06-10FY16 Q4 Financial Result - Transcript (PDF)
2016-06-06Press Conference Invitation (PDF)
2016-06-04Sun Pharma announces divestment of US manufacturing units (PDF)
2016-05-30FY16 Q4 Financial Press Release (PDF)
2016-05-19Sun Pharma to announce fourth quarter results on May 30, 2016 (PDF)
2016-05-09Sun Pharma leverages mobile technology to boost treatment compliance amongst asthma patients (PDF)
2016-05-04Sun Pharma Announces Positive Results of Two Pivotal Phase-3 Clinical Trials of Tildrakizumab in Patients with Moderate-... (PDF)
2016-04-29Media Invitation - Signing of Novel Drug Development Agreement, May 4, 2016 (PDF)
2016-04-21Press Conference Invitation, April 25, New Delhi (PDF)
2016-04-10Sun Pharma Receives USFDA Approval For BromSite™ (PDF)
2016-03-29Sun Pharma enters Japanese prescription market (PDF)
2016-03-23Sun Pharma and AstraZeneca India enter partnership in Type 2 diabetes (PDF)
2016-03-08Sun Pharma Global Consumer Healthcare signs Indian cricket captain MS Dhoni as Revital H brand ambassador (PDF)
2016-02-26FY16 Q3 Earnings Call Transcript (PDF)
2016-02-12FY16 Q3 Financial Press Release (PDF)
2016-02-01Sun Pharma launches Imatinib Mesylate in USA
2016-01-30Sun Pharma to announce third quarter results on February 12, 2016 (PDF)
2016-01-27Revital H announces association with Patna Pirates, Kabbadi Team as Official Health Partner (PDF)
2016-01-04Transcript - Warning Letter received for Halol facility (PDF)
2016-01-04Transcript - Update on Halol facility (PDF)
2015-12-19Sun Pharma receives Warning Letter for Halol facility (PDF)
2015-12-14Sun Pharma announces divestment of US manufacturing unit (PDF)
2015-12-10Sun Pharma announces research collaboration with Weizmann Institute of Science, Israel & Health Research Institute of Sa... (PDF)
2015-12-04Sun Pharma announces US FDA approval for generic Gleevec® (PDF)
2015-12-02Sun Pharma announces its association with World Champion Snowboarder Kelly Clark for Absorica® (PDF)
2015-11-27Earning Call Transcript (PDF)
2015-11-27FY16 Q2 Earnings Call Transcript (PDF)
2015-11-07FY16 Q2 Financial Press Release (PDF)
2015-11-03Sun Pharma Successfully Acquires InSite Vision (PDF)
2015-11-03Volini announces Sania Mirza and Sunil Chhetri as brand ambassadors (PDF)
2015-10-28Sun Pharma completes tender offer for InSite Vision (PDF)
2015-10-26Sun Pharma Q2 & H1 FY16 financial results on November 07, 2015 (PDF)
2015-10-05Sun Pharma announces Absorica patent litigation settlement (PDF)
2015-09-29Sun Pharma commences Tender Offer for Acquisition of InSite Vision (PDF)
2015-09-19Strides Arcolab acquires CNS divisions of erstwhile Ranbaxy (PDF)
2015-09-16Sun Pharma to acquire InSite Vision (PDF)
2015-09-01Sun Pharma announces successful completion of Opiates business acquisition in Australia (PDF)
2015-08-25FY16 Q1 Earnings Call Transcript (PDF)
2015-08-19Sun Pharma announces US FDA approval for Ximino (PDF)
2015-08-11FY16 Q1 Financial Press Release (PDF)
2015-07-29Sun Pharma to announce first quarter results on August 11, 2015 (PDF)
2015-07-24Transcript - Sun Pharma Business Update (PDF)
2015-07-20Sun Pharma provides business update (PDF)
2015-07-20Webcast - Sun Pharma Business Update
2015-06-16FY15 Q4 Earning Call Transcript (PDF)
2015-06-09SPARC Licenses XelprosTM (Latanoprost BAK-free) to Sun Pharma (PDF)
2015-06-02Sun Pharma and AstraZeneca enter into distribution agreement for ticagrelor in India (PDF)
2015-05-29FY15 Q4 Financials Press Release (PDF)
2015-05-15Sun Pharma to announce fourth quarter FY15 results on May 29, 2015 (PDF)
2015-04-15Sun Pharma and the Technion form Research Collaboration to Develop New Class of Oncology Drugs (PDF)
2015-03-25Sun Pharma announces closure of merger deal with Ranbaxy
2015-03-25Press Conference Webcast: Sun Pharma - Ranbaxy Merger
2015-03-03Sun Pharma to buy GSK’s Opiates business in Australia (PDF)
2015-02-24FY15 Q3 Earning Call Transcript (PDF)
2015-02-14Press Release SPIL Financials Q3 FY15 (PDF)
2015-02-09Sun Pharma to announce third quarter results on February 14, 2015 (PDF)
2015-02-02Sun Pharma receives US FTC clearance for Ranbaxy acquisition (PDF)
2014-12-08CCI approves Ranbaxy acquisition by Sun Pharma (PDF)
2014-10-30Sun Pharma to announce second quarter results on November 13, 2014 (PDF)
2014-09-17Sun Pharma and Merck & Co. Inc. Enter into Licensing Agreement for Tildrakizumab (PDF)
2014-09-04Form IV contained in Schedule II to the Combination Regulations under Sec 29(2) of Competition Act, 2002 (as amended) (PDF)
2014-08-23Q1 FY15 Earnings Call Transcript (PDF)
2014-08-12Q1 FY15 Financial Press Release (PDF)
2014-07-30Sun Pharma to announce first quarter results on August 12, 2014 (PDF)
2014-07-16Sun Pharma acquires Pharmalucence (PDF)
2014-05-29Q4 FY14 Financial Press Release (PDF)
2014-05-16Sun Pharma to announce Q4 and FY14 results on May 29, 2014 (PDF)
2014-05-15Sun Pharma announces settlement of litigation for generic Gleevec® in US (PDF)
2014-05-02Sun Pharma announces manufacturing consolidation (PDF)
2014-04-16Transcript Sun Pharma - Ranbaxy Merger Conference Call (PDF)
2014-04-09Clarification on Silverstreet Investment in Ranbaxy (PDF)
2014-04-07Investor Presentation: Sun Pharma & Ranbaxy merger (PDF)
2014-04-07Sun Pharma to acquire Ranbaxy in a US$ 4 billion landmark transaction (PDF)
2014-03-13Press Release Import Alert for Karkhadi unit from US FDA (PDF)
2014-02-25FY14 Q3 Earnings call transcript (PDF)
2014-02-13Rekha Sethi appointed as an additional independent director of Sun Pharma Board (PDF)
2014-02-13FY14 Q3 Financial Press Release (PDF)
2014-02-13Sun Pharma announces US FDA approval for generic Temodar® (PDF)
2014-01-29Sun Pharma to announce third quarter results on February 13, 2014 (PDF)
2013-12-12Sun Pharma announces US FDA approval for generic Cymbalta® (PDF)
2013-11-22FY14 Q2 Earnings call transcript (PDF)
2013-11-13FY14 Q2 Financial Press Release (PDF)
2013-10-28Sun Pharma to announce second quarter results on November 13, 2013 (PDF)
2013-10-01Sun Pharma and Intrexon Form Joint Venture to Develop New Class of Therapeutics for Ocular Diseases (PDF)
2013-09-14Sun Pharma announces USFDA approval for generic Prevacid® (PDF)
2013-08-09FY14 Q1 Financial Press Release (PDF)
2013-07-23Sun Pharma to announce first quarter results on August 09, 2013 (PDF)
2013-07-12Sun Pharma announces USFDA approval for generic Prandin® (PDF)
2013-06-12Press Release Sun Pharma settles generic Protonix® litigation (PDF)
2013-06-12FY13 Q4 Earnings Call Transcript (PDF)
2013-06-04Sun Pharma announces USFDA approval for generic Depo®-Testosterone Injection (PDF)
2013-05-29Sun Pharma Announces 1:1 Bonus (PDF)
2013-05-28Sun Pharma reports strong performance (PDF)
2013-05-17Sun Pharma to announce Q4 and FY13 results on May 28, 2013 (PDF)
2013-04-13Sun pharma announces Tentative USFDA approval for generic Januvia & Glumetza (PDF)
2013-02-08Sun Pharma and Taro Announce Termination of Proposed Transaction (PDF)
2013-02-05Sun Pharma announces USFDA approval for generic Doxil® (PDF)
2013-01-25Sun Pharma to announce third quarter results on February 08, 2013 (PDF)
2012-12-20Successful acquisition of DUSA Pharmaceuticals, Inc.U.S.A.by our subsidiary (PDF)
2012-12-17Sun Pharma acquire URL generic business from Takeda (PDF)
2012-11-08Sun Pharma to acquire DUSA Pharmaceuticals, Inc. (PDF)
2012-10-22Sun Pharma to announce second quarter results on November 08, 2012 (PDF)
2012-08-28Caraco receives USFDA clearance to resume operations (PDF)
2012-08-13Sun Pharma to take Taro Private (PDF)
2012-07-30Sun Pharma to announce first quarter results on August 10, 2012 (PDF)
2012-05-29Israel Makov appointed chairman of Sun Pharma Board (PDF)
2012-05-24Sun Pharma announces USFDA approval for generic Astelin® Nasal Spray (PDF)
2012-05-18Sun Pharma announces USFDA approval for generic Plavix® tablets (PDF)
2012-05-15Sun Pharma to announce Q4 and FY12 results on May 29, 2012 (PDF)
2012-04-24Sun Pharma announces USFDA approval for generic Zyprexa® tablets (PDF)
2012-04-18Favorable Ruling by United States Supreme Court on Prandin® Litigation (PDF)
2012-03-28Sun Pharma announces USFDA approval for generic Seroquel® tablets (PDF)
2012-02-29Sun Pharma announces USFDA approval for generic Zyprexa Zydis® tablets (PDF)
2012-02-15Sun Pharma: An update on generic Protonix® litigation (PDF)
2012-01-31Sun Pharma to announce Q3 FY12 results on February 13, 2012 (PDF)
2011-12-09Sun Pharma announces USFDA approval for generic Ultram® ER tablets (PDF)
2011-11-03Sun Pharma to announce Q2 FY12 results on November 13, 2011 (PDF)
2011-10-31Sun Pharma announces USFDA approval for generic Cardizem CD® (PDF)
2011-09-19Sun Pharma subsidiary resolves USFDA warning letter (PDF)
2011-07-29Sun Pharma announces USFDA tentative approval for generic Plavix® tablets (PDF)
2011-07-19Sun Pharma to announce Q1 FY12 results on July 28, 2011 (PDF)
2011-07-19Sun Pharma announces USFDA approval for generic Uroxatral® ER tablets Company gets 180 day marketing exclusivity on fir... (PDF)
2011-06-21Sun Pharma announces USFDA approval for generic Imitrex® injection (PDF)
2011-05-14Sun Pharma to announce Q4 and FY11 financial results on May 28, 2011 (PDF)
2011-05-04Sun Pharma announces USFDA approval for DOCEFREZTM (docetaxel) for Injection (PDF)
2011-04-25Sun Pharma to co-market MSD's sitagliptin in India (PDF)
2011-04-20Call Transcript: Sun Pharma & Merck JV announcement (PDF)
2011-04-11Sun Pharma and Merck Establish joint venture to develop and commercialize novel formulations and combinations of medicin... (PDF)
2011-02-03Sun Pharma announces USFDA approval for generic Razadyne® ER (PDF)
2011-01-18Sun Pharma to announce Q3FY11 results on Jan 31, 2011 (PDF)
2010-12-30Sun Pharma announces USFDA tentative approval for generic Boniva® (PDF)
2010-11-30Sun Pharma announces USFDA tentative approval for generic Aricept® (PDF)
2010-11-24Sun Pharma announces USFDA tentative approval for generic Cymbalta® (PDF)
2010-11-18Sun Pharma announces USFDA approval for generic Clarinex® (PDF)
2010-11-18Sun Pharma announces USFDA approval for generic Diltiazem ER® (PDF)
2010-10-19Sun Pharma to announce Q2FY11 results on Oct 30, 2010 (PDF)
2010-10-01Sun Pharma announces USFDA tentative approval for generic Stalevo® (PDF)
2010-09-29Sun Pharma announces USFDA tentative approval for generic Crestor® (PDF)
2010-09-29Sun Pharma announces expiration of subsequent offering period (PDF)
2010-09-28Sun Pharma announces USFDA tentative approval for generic Rilutek® (PDF)
2010-09-22Sun Pharma acquires controlling stake in Taro (PDF)
2010-09-15Sun Pharmaceutical announces expiration of offer for Taro (PDF)
2010-09-08Supreme court of Israel rules in favor of Sun Pharma (PDF)
2010-08-31Sun Pharma announces USFDA approval for generic Strattera® Capsules (PDF)
2010-08-31Sun Pharma subsidiary receives warning letter from USFDA (PDF)
2010-08-19Sun Pharma announces USFDA approval for generic Venlafaxine ER® Tablets (PDF)
2010-07-29US appeals court rules Gemzar® patent invalid (PDF)
2010-07-17Sun Pharma: an update on generic Protonix litigation® (PDF)
2010-07-16Sun Pharma announces USFDA approval for generic Flomax® (PDF)
2010-07-15US district court rules in favor of Sun Pharmaceutical dismisses all of Taros claims (PDF)
2010-07-13Sun Pharma to announce Q1FY11 results on July 28, 2010 (PDF)
2010-06-26Sun Pharma: an update on generic Eloxatin® injection (PDF)
2010-06-22Sun Pharma settles litigation over generic Stalevo® and Comtan® (PDF)
2010-06-21Investor news Sun Pharma announces USFDA approval for generic Optivar® (PDF)
2010-06-18Sun Pharma announces USFDA approval for generic Xanax® Tablets (PDF)
2010-06-17Sun Pharma announces USFDA approval for generic Keppra® Injection, levetiracetam® injection (PDF)
2010-04-10Sun Pharma announces USFDA tentative approval for generic Namenda® tablets (PDF)
2010-04-08Sun Pharma announces USFDA approval for generic Wellbutrin® SR extended release tablets (PDF)
2010-03-18Sun Pharma announces USFDA approval for generic Prometh® syrup (PDF)
2010-01-11Sun Pharma sends letter to directors of Taro (PDF)
2009-08-25Generic Eloxatin® and Imitrex® approval: shares 180-day marketing drug exclusivity for generic Eloxatin® (PDF)
2009-08-03Sun Pharma signs agreement with MedImmune for generic Ethyol® (PDF)
2009-07-10Sun Pharma to license key Escitalopram® patent applications to Lundbeck (PDF)
2009-07-07Sun Pharma announces USFDA approval for generic Casodex® tablets (PDF)
2009-07-02Conference call transcript - FDA seizure at Caraco, June 2009 (PDF)
2009-07-02Sun Pharma announces USFDA tentative approval for generic Optivar® (PDF)
2009-06-26Sun Pharma to hold conference call on June 27, 2009 (PDF)
2009-06-19Sun Pharma announces USFDA approval for generic Accupril® tablets (PDF)
2009-05-18Sun Pharma to announce FY09 results on May 30. Earnings call on June 1, 2009. (PDF)
2009-05-07Sun Pharma announces USFDA tentative approval for generic Uroxatral® extended release tablets (PDF)
2009-04-13Sun Pharma announces USFDA approval to market generic Roxicodone® tablets (PDF)
2009-03-28Sun Pharma announces USFDA approval to market generic Topamax® tablets (PDF)
2009-03-20Sun Pharma extends tender offer for Taro to april 3, 2009 (PDF)
2009-03-06Sun Pharma extends tender offer for Taro to Mar 20, 2009 (PDF)
2009-01-29Sun Pharma extends tender offer for Taro to March 6, 2009 (PDF)
2009-01-24Sun Pharma Q3 results on Jan 30; conf call on Jan 31 (PDF)
2009-01-07Sun Pharma receives USFDA approvals for 4 generic products; company receives its first controlled substance product appr... (PDF)
2009-01-07Sun Pharmaceutical extends tender offer for Taro to January 30, 2009 (PDF)
2008-12-19Sun Pharmaceutical extends tender offer for Taro to January 9, 2009 (PDF)
2008-11-27Sun Pharma update on ANDA for generic Effexor XR: USFDA grants Osmotica's citizen petition (PDF)
2008-11-25Sun Pharma subsidiary acquires 100% of Chattem Chemicals, Inc. a US based DEA registered narcotic API importer & produce... (PDF)
2008-11-07Sun Pharmaceutical extends tender offer for Taro to Dec 19, 2008 (PDF)
2008-11-05Sun Pharmaceutical announces USFDA approval to market generic Sinemet® tablets (PDF)
2008-10-15Sun Pharma to announce Q2 and H1 2008-09 results on Oct 25, 2008 (PDF)
2008-10-03Sun Pharma extends tender offer for Taro (PDF)
2008-09-23Sun Pharma announces USFDA approval to market generic Paraplatin® injection (PDF)
2008-09-12Sun Pharma gets USFDA approval for generic Fosamax® tablets (PDF)
2008-09-03Sun Pharmaceutical extends tender offer for Taro (PDF)
2008-08-27Sun to file amendment to tender offer for Taro waiving certain conditions (PDF)
2008-08-27Tel-Aviv court rules in favor of Sun Pharmaceutical; no special tender offer neccessary in Taro offer (PDF)
2008-08-25Sun Pharmas second letter to Taro Pharma regarding Taro's Irish subsidiary (PDF)
2008-08-14Sun Pharma announces US FTC clearance (PDF)
2008-07-30Sun Pharma gets USFDA approval for generic Depakote® delayed release tablets (PDF)
2008-07-28Sun Pharma reaffirms commitment to Taro facilities and employees (PDF)
2008-06-30Sun Pharma commences tender offer for Taro shares (PDF)
2008-06-26Sun Pharma exercises its options to acquire the shares of the controlling shareholders of Taro Pharma (PDF)
2008-06-05Sun Pharma comments on Taros potential sale of its Irish operations (PDF)
2008-05-30Sun Pharma responds to Taros purported termination of merger agreement (PDF)
2008-05-28Sun Pharma receives notice for termination of merger from Taro (PDF)
2008-05-19Q4 2007-08 results on 30 May, 2008; earnings call on 30 May, 2008 at 6:30 PM IST (PDF)
2008-03-31Sun Pharmaceutical announces launch of generic Ethyol® (180 days exclusivity) (PDF)
2008-03-21Sun Pharmaceutical announces USFDA approval to market generic Tessalon® (PDF)
2008-03-19Sun Pharmaceutical announces USFDA approval to market generic Cerebyx® (PDF)
2008-03-15Sun Pharmaceutical announces USFDA approval to market generic Ethyol® (With 180 day marketing exclusivity) (PDF)
2008-03-05Sun Pharma gets USFDA tentative approval for generic Gemzar® injection (PDF)
2008-02-27Sun Pharma gets USFDA approval to market generic Demadex® Tablets (PDF)
2008-02-19Sun Pharma buys additional 9.4% stake in Taro Pharma from Brandes (PDF)
2008-02-14Sun Pharma gets USFDA tentative approval for generic Depakote® delayed release tablets (PDF)
2008-01-30Sun Pharma launches generic Protonix ® Tablets (PDF)
2008-01-16Sun Pharma Q3 2007-08 results on 30 Jan, 2008; earnings call on January 31, 2008 on 10:00 am IST (PDF)
2007-12-06Sun Pharma announces settlement of litigation over generic Exelon® (PDF)
2007-10-24Sun Pharma announces USFDA approval to market generic Exelon® Capsules (PDF)
2007-10-17Sun Pharma receives will-not-sue covenant on generic Effexor XR ® ANDA (PDF)
2007-10-10Sun Pharma announces USFDA approval to market generic Trileptal® Tablets, 180 day marketing exclusivity (PDF)
2007-10-10Sun Pharma 2Q 2007-08 results on Oct 25, 2007; earnings call on Oct 26 at 10 am IST (PDF)
2007-09-11Sun Pharma announces USFDA approval to market generic Protonix Tablets - Company gets it's first 180 day marketing exclu... (PDF)
2007-08-30USFDA grants tentative approval for Sun Pharma's ANDA for Galantamine tablets (PDF)
2007-08-25Sun Pharma announces USFDA approval for Sinemet CR, an extended release version of Carbidopa with Levodopa (PDF)
2007-08-19Sun Pharma announces USFDA approval to market generic Octreotide injection (PDF)
2007-07-26Investor presentation (PDF)
2007-07-19Notice of extraordinary general meeting on July 28, 2007 (PDF)
2007-05-21Sun Pharma to acquire Taro Pharma in a USD 454 million deal (PDF)
2007-05-18Sales growth 30%, profit increased 35%, R&D spend Rs. 2924 million (PDF)
2007-05-14Apportionment of cost between SPIL and SPARC (PDF)
2007-05-14Way forward on demerger (PDF)
2007-03-26Transcript of management presentation on NCE and NDDS (PDF)
2007-03-16Management presentation on NCE and NDDS (PDF)
2007-03-12Announcement of a management presentation on NCE and NDDS (PDF)
2007-01-29Q3 sales up 27%, net profit up 36% (PDF)
2007-01-173rd Quarter 2006-07 results on 29 Jan 2007, call on 30 Jan at 0930 (PDF)
2006-10-20Sun Pharma's lead molecule enters Phase II in the US (PDF)
2006-10-09Second quarter results on Oct. 19 (PDF)
2006-02-10Q & A demerger (PDF)
2006-02-10Conference call transcript- innovative R&D demerger (PDF)
2006-02-09Board clears demerger proposal (PDF)
2006-02-07Conference call: Demerger (PDF)
2006-01-30Sun Pharma's board to meet Jan 30: Q3 results (PDF)
2005-12-23Sun Pharma closes Able Labs acquisition in the US (PDF)
2005-10-18Sun Pharma H1 results on Oct 28 (PDF)
2005-10-04Sun Pharma shares plans: recent Hungarian and US acquisitions (PDF)
2005-09-14Sun Pharma buys manufacturing facility in Bryan, Ohio (PDF)
2005-08-10Sun Pharma to buy manufacturing site in Hungary (PDF)
2005-07-28Sun Pharma Q1 post results conference call on Thursday July 28 at 11am IST (PDF)
2005-07-18Sun Pharma board to meet July 27 (PDF)
2005-06-06Q4 results on June 6, conf call June 7 (PDF)
2005-05-12Sun Pharma to donate hostel for medical college (PDF)
2005-05-06Sun Pharma shares guidance for 2005-2006 (PDF)
2005-04-28Quarter 4 conference call on April 28 at 10am (PDF)
2005-01-21Q3 result conference Call (PDF)
2004-12-07President to inaugurate Sun Pharma's research center (PDF)
2004-12-03Sun Pharma launches additional US$75mill FCCB (PDF)
2004-11-29Sun Pharma declares interim dividend (PDF)
2004-11-27Sun Pharma completes $275 mill FCCB (PDF)
2004-11-18Sun Pharma launches $225 mill FCCB Issue (PDF)
2004-10-18Sun Pharma board to meet on Oct 21: first half results (PDF)
2004-09-23Sun Pharma to buy 3 US brands for $5.4 mill Entry in brand market in North America (PDF)
2004-08-06Fire in Unit 1 at Panoli (PDF)
2004-08-04Sun Pharma: flood at plant sites (PDF)
2004-08-02Sun Pharma Q1 post results conference call on Monday, August 2 at 11.00 am (PDF)
2004-07-31Sun Pharma announces swap ratio for Phlox Pharma merger (PDF)
2004-07-19Sun Pharma board to meet July 31: Q1 results (PDF)
2004-07-06Sun Pharma to acquire a bulk active company :: Phlox Pharma has EDMF approval, UKMCA / USFDA compliant plant (PDF)
2004-06-21Fire put out at Sun Pharma’s corporate offices (PDF)
2004-05-29Record date for bonus is May 29 (PDF)
2004-05-27Buyback of 6% cumulative redeemable preference shares (PDF)
2004-05-26Sun Pharma's bulk active and tablet manufacturing factories are cleared by USFDA (PDF)
2004-05-17Letter to the stock exchange for result correction (PDF)
2004-04-23No such proposal, says Sun Pharma Bloomberg story titled " Sun Pharma plans to acquire remaining stake in Caraco" (PDF)
2004-04-22Sun Pharma Q4 post results conference call on Thursday April 22, 12 noon (PDF)
2004-04-211:1 Bonus announced exports jumps 48%; powers profit growth PAT up 21.2%, total income up 20.8%, R&D expense 11.7% of tu... (PDF)
2004-04-13Sun Pharma board to meet April 21: Audited financial results (PDF)
2004-04-08Sun Pharma to raise $350mill, EGM announced (PDF)
2004-04-02Sun Pharma board to meet; to consider issue of convertible debentures (PDF)
2004-03-13Sun Pharma hikes stake in Caraco to 63.14% (PDF)
2004-03-09Clarification on news items regarding acquisition of HAL (PDF)
2004-02-03Sun Pharma purchases additional stake in Caraco to hold over 60 % equity (PDF)
2004-02-02Mr. Ashwin Dani joins Sun Pharma board (PDF)
2004-01-28Q3 results conf call Jan 28/5pm IST (PDF)
2004-01-28Unaudited Q3 numbers on January 28 (PDF)
2003-10-22Sun Pharma H1 post results conference call on Wednesday October 22, 11am (PDF)
2003-10-21Sun Pharma to announce unaudited H1 numbers on October 21 (PDF)
2003-07-28Sun Pharma to announce unaudited q1 numbers on July 28 (PDF)
2003-07-28Sun Pharma conference call after the Q1 results on Monday, July 28 (PDF)
2003-07-17Conference call after the Q1 results on Monday, July 28 (PDF)
2003-05-05Q4 conf call on May5 (PDF)
2003-04-25Sun Pharma to announce audited q4 numbers on May 3 (PDF)
2003-02-14DMF approval for Metaprolol tartrate received (PDF)
2003-01-30Q3 conf call announcement for Jan 30 (PDF)
2003-01-20Q3 numbers on January 30 (PDF)
2002-12-20EGM clears resolutions for split, buyback (PDF)
2002-10-28Sun Pharma board proposes buyback plan (PDF)
2002-10-21Q2 results on October 28, 2002 (PDF)
2002-09-10Biostudy volunteer in hospital with pneumonia (PDF)
2002-08-29Mr Keki Mistry joins Sun Pharma's board of directors (PDF)
2002-08-28AGM approves bonus preference. (PDF)
2002-07-28Sun Pharma announces Bonus Preference Shares carrying coupon of 6% in ratio of 4 shares of Rs 1/- each per 1 equity shar... (PDF)
2002-07-22Conference call after the Q1 unaudited numbers on Monday, July 22 (PDF)
2002-07-16Sun Pharma launches anticancer with novel biodegradable microsphere technology product readily available at distribution... (PDF)
2002-05-31Sun Pharma announces audited numbers, dividend, bonus preference, M J Pharma swap record date (PDF)
2002-05-27Sun Pharmas board to meet: audited accounts, MJ Pharma merger (PDF)
2002-04-23Earnings conference call (PDF)
2002-03-30Offer letter to shareholders-regional stock exchanges delisting (PDF)
2002-03-28Sun Pharma's new plant at Dadra commences operations (PDF)
2001-08-10Sun Pharma launches Smoquit (PDF)
2001-03-23Hasmukh Shah joins Sun Pharma board (PDF)
2001-02-26PDC ratio is 500 : 1. (PDF)
2001-02-10Board to meet to consider merger of Pradeep Drugs. (PDF)
2001-01-20Sun Pharma clarifies on news stories. (PDF)
2000-03-31Sun Pharma board to consider merger of export subsidiary (PDF)
2000-03-18Press release for second interim dividend (PDF)
2000-03-18Sun Pharma declares 40% second interim dividend (PDF)
2000-02-01Press release for the bonus share issue (PDF)
2000-02-01Sun Pharma announces bonus (PDF)
2000-01-21Sun Pharma board to consider bonus on Feb 1 (PDF)
1999-11-26Press release for the merger of Milmet Laboratories Pvt. Ltd. (PDF)
1999-11-06Sun Pharma declares 60% interim dividend (PDF)
1999-10-25Sun Pharma to set up new research campus in Chennai (PDF)
1999-10-25Press release for the proposed research campus at Chennai (PDF)
1999-09-11CLARIFICATION- No intimation from BIFR (PDF)
1999-08-18CLARIFICATION Chennai Plant (PDF)
1999-04-08BIFR Okays GLOL merger (PDF)
Brought to you by PharmiWeb.com - Latest Jobs in Pharma
Brought to you by www.pharmiweb.com - Latest Jobs in Pharma.